|
1）Bobo RH, Laske DW, Akbasak A, et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A. 1994; 91: 2076-80
|
|
|
|
2）Kunwar S, Chang S, Westphal M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 2010; 12: 871-81
|
|
|
|
|
|
3）Sampson JH, Archer G, Pedain C, et al. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg. 2010; 113: 301-9
|
|
|
|
|
|
4）Bidros DS, Liu JK, Vogelbaum MA. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol. 2010; 6: 117-25
|
|
|
|
|
|
5）Gill T, Barua NU, Woolley M, et al. In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain. J Neurosci Methods. 2013; 219: 1-9
|
|
|
|
|
|
6）Krauze MT, Saito R, Noble C, et al. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg. 2005; 103: 923-9
|
|
|
|
|
|
7）Lewis GK Jr, Schulz ZR, Pannullo SC, et al. Ultrasound-assisted convection-enhanced delivery to the brain in vivo with a novel transducer cannula assembly: laboratory investigation. J Neurosurg. 2012; 117: 1128-40
|
|
|
|
|
|
8）Hood RL, Andriani RT Jr, Emch S, et al. Fiber-optic microneedle device facilitates volumetric infusate dispersion during convection-enhanced delivery in the brain. Lasers Surg Med. 2013; 45: 418-26
|
|
|
|
|
|
9）Barua NU, Lowis SP, Woolley M, et al. Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma. Acta Neurochir (Wien). 2013; 155: 1459-65
|
|
|
|
|
|
10）Rosenbluth KH, Eschermann JF, Mittermeyer G, et al. Analysis of a simulation algorithm for direct brain drug delivery. Neuroimage. 2012; 59: 2423-9
|
|
|
|
|
|
11）Kim JH, Astary GW, Kantorovich S, et al. Voxelized computational model for convection-enhanced delivery in the rat ventral hippocampus: comparison with in vivo MR experimental studies. Ann Biomed Eng. 2012; 40: 2043-58
|
|
|
|
|
|
12）Sugiyama S, Saito R, Funamoto K, et al. Computational simulation of convection enhanced drug delivery in the non-human primate brainstem: a simple model predicting the drug distribution. Neurol Res. 2013; 35: 773-81
|
|
|
|
|
|
13）Zhou J, Patel TR, Sirianni RW, et al. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A. 2013; 110: 11751-6
|
|
|
|
|
|
14）Weng KC, Hashizume R, Noble CO, et al. Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (Lond). 2013 Apr 30. [Epub ahead of print]
|
|
|
|
|
|
15）Chen PY, Ozawa T, Drummond DC, et al. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Neuro Oncol. 2013; 15: 189-97
|
|
|
|
|
|
16）Chandramohan V, Bao X, Kato Kaneko M, et al. Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int J Cancer. 2013; 132: 2339-48
|
|
|
|
|
|
17）Chandramohan V, Bao X, Keir ST, et al. Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy. Clin Cancer Res. 2013; 19: 4717-27
|
|
|
|
|
|
18）Yin D, Zhai Y, Gruber HE, et al. Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model. Cancer Gene Ther. 2013; 20: 336-41
|
|
|
|
|
|
19）San Sebastian W, Richardson RM, Kells AP, et al. Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther. 2012; 23: 210-7
|
|
|
|
|
|
20）Hdeib A, Sloan A. Targeted radioimmunotherapy: the role of 131I-chTNT-1/B mAb (Cotara) for treatment of high-grade gliomas. Future Oncol. 2012; 8: 659-69
|
|
|
|
|
|
21）Bruce JN, Fine RL, Canoll P, et al. Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery. 2011; 69: 1272-9
|
|
|
|
|
|
22）Saito R, Sonoda Y, Kumabe T, et al. Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride. J Neurosurg Pediatr. 2011; 7: 522-6
|
|
|
|
|
|
23）Bogdahn U, Hau P, Stockhammer G, et al. Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro Oncol. 2011; 13: 132-42
|
|
|
|
|
|
24）Sampson JH, Desjardins A, Peters KB, et al. Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma. Neurosurgery. 2013; 60 Suppl 1: 155
|
|
|
|
|